Tag: Assembly Biosciences

Assembly Biosciences delivered a stunning market surprise with exceptional clinical data for its investigational herpes treatment, ABI-5366. The biopharmaceutical company's ...

Assembly Biosciences finds itself at the center of a classic Wall Street debate, with prominent research firms issuing starkly conflicting ...

Assembly Biosciences shares are demonstrating remarkable upward momentum, fueled by a pivotal technical achievement that suggests the bull run has ...

Assembly Biosciences shares extended their decline for a third consecutive session, closing Thursday's trading at $24.67 after shedding 3.37% of ...

The downward trajectory for Assembly Biosciences shares intensified during the latest trading session, marking a third consecutive day of declines. ...

A significant vote of confidence has emerged for Assembly Biosciences, with JMP Securities initiating coverage of the biopharmaceutical company. The ...

A wave of positive analyst sentiment is bolstering the outlook for Assembly Biosciences, with Citizens JMP initiating coverage on the ...

Assembly Biosciences shares are experiencing a significant correction phase. The biotechnology stock has now recorded losses for three consecutive trading ...

Assembly Biosciences is experiencing a significant boost, propelled by two powerful catalysts: a substantial capital infusion from a partnership with ...

Investment firm Guggenheim has issued a bullish update on Assembly Biosciences, increasing its price target for the biopharmaceutical company to ...